Which has grown faster, INCY or MRNA?

Over the past five years, INCY grew revenue faster — INCY at a 14.68% CAGR versus MRNA at -2.60%.

Is INCY or MRNA more profitable?

INCY runs the higher net margin — INCY at 26.71% versus MRNA at -143.55%.

Which has been the better investment, INCY or MRNA?

Over the past 5-year, INCY delivered the higher annualized total return — INCY at 3.49% versus MRNA at -22.79%. Past performance doesn't predict future results.

Incyte Corporation (INCY) vs Moderna, Inc. (MRNA)

INCY leads on 8 of 10 compared metrics.

A side-by-side comparison of Incyte Corporation and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 25, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — INCY vs MRNA

growth of $100 · last 8y

INCY +68.1%MRNA +224.8%MRNA compounded faster

INCY MRNA

INCY vs MRNA: by the numbers

•MRNA is the larger company ($23.97B vs $21.67B market cap).
•INCY is profitable (26.71% net margin) while MRNA runs a net loss (-143.55%).
•INCY grew revenue faster over the past five years (14.68% vs -2.60% CAGR).

Which is better, INCY or MRNA?

Metric tally: INCY 8 · MRNA 2

It depends on what you're optimizing for:

GrowthINCY(faster 5Y revenue CAGR)

QualityINCY(higher ROIC)

Metrics side by side

Valuation

Metric	INCY	MRNA
P/E ratio	15.32	—
Forward P/E	12.18	—
P/S ratio	4.18●	10.73
P/B ratio	4.04	3.22●
PEG ratio	0.72	—
EV / EBITDA	10.16	—
FCF yield	6.47%	—

Profitability

Metric	INCY	MRNA
Gross margin	92.48%●	-13.89%
Operating margin	27.05%●	-153.35%
Net margin	26.71%●	-143.55%
ROE	25.79%●	-43.12%
ROIC	20.58%●	-29.70%

Growth (annualized)

Metric	INCY	MRNA
Revenue CAGR (5Y)	14.68%●	-2.60%
EPS CAGR (5Y)	21.19%	—
FCF CAGR (5Y)	20.60%	126.92%●
Total return CAGR (5Y)	4.72%●	-22.79%

Frequently asked

Which is better, INCY or MRNA?: It depends on your goal. growth: INCY (faster 5Y revenue CAGR); quality: INCY (higher ROIC). Across all compared metrics, INCY leads 8 to 2.
Which has grown faster, INCY or MRNA?: Over the past five years, INCY grew revenue faster — INCY at a 14.68% CAGR versus MRNA at -2.60%.
Is INCY or MRNA more profitable?: INCY runs the higher net margin — INCY at 26.71% versus MRNA at -143.55%.
Which has been the better investment, INCY or MRNA?: Over the past 5-year, INCY delivered the higher annualized total return — INCY at 3.49% versus MRNA at -22.79%. Past performance doesn't predict future results.

Go deeper

Full INCY analysis Full MRNA analysis Interactive comparison tool

Dig into the metrics

Incyte P/E ratio Moderna P/E ratio Incyte dividend yield Moderna dividend yield Incyte ROE Moderna ROE Incyte operating margin Moderna operating margin Incyte revenue growth Moderna revenue growth Incyte free cash flow Moderna free cash flow

Incyte & Moderna appear in these rankings

Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 25, 2026.